Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…
BRIM Biotechnology, Inc.has entered OTC (over the counter) trading in Taiwan. Established in July 2013,…
A bio-manufacturing company based in Shanghai has bagged $80 million in funding to advance its…
Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in…
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
Emergency authorization was granted for the use of the Pfizer-BioNTech Covid-19 vaccines on children from…
Researchers at Rensselaer Polytechnic Institute in Troy, NY, have developed N95 surgical face masks that…
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…